Increased accumulation of regulatory granulocytic myeloid cells in mannose receptor C type 1-deficient mice correlates with protection in a mouse model of neurocysticercosis

Infection and Immunity

Volumn 81, Issue 4, 2013, Pages 1052-1063

  Mishra, Pramod Kumar ^a   Morris, Elizabeth G ^b   Garcia, Jenny A ^b   Cardona, Astrid E ^b   Tealea, Judy M ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; MANNOSE RECEPTOR; MANNOSE RECEPTOR C 1; RANTES; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL INFILTRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; GRANULOCYTIC MYELOID CELL; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MESOCESTOIDEA; MOUSE; NEUROCYSTICERCOSIS; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN FUNCTION; SURVIVAL TIME; WILD TYPE;

ANIMALS; BRAIN; CYTOKINES; FEMALE; GRANULOCYTE PRECURSOR CELLS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MEMBRANE GLYCOPROTEINS; MESOCESTOIDES; MICE; MICE, INBRED C57BL; NEUROCYSTICERCOSIS; RECEPTORS, CELL SURFACE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84875515946     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01176-12     Document Type: Article

References (73)

1. Garcia HH, Del Brutto OH. 2005. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 4:653-661.
2. Garcia HH, Gonzalez AE, Evans CA, Gilman RH. 2003. Taenia solium cysticercosis. Lancet 362:547-556.
3. Fleury A, Dessein A, Preux PM, Dumas M, Tapia G, Larralde C, Sciutto E. 2004. Symptomatic human neurocysticercosis-age, sex and exposure factors relating with disease heterogeneity. J. Neurol. 251:830-837.
4. San-Juan Orta D. 2009. Clinical manifestations of neurocysticercosis. Neurologia 24:331-335. (In Spanish.)
5. White AC, Jr, Robinson P, Kuhn R. 1997. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem. Immunol. 66:209-230.
6. White AC, Jr. 2000. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annu. Rev. Med. 51:187-206.
7. Nash TE, Singh G, White AC, Rajshekhar V, Loeb JA, Proano JV, Takayanagui OM, Gonzalez AE, Butman JA, DeGiorgio C, Del Brutto OH, Delgado-Escueta A, Evans CA, Gilman RH, Martinez SM, Medina MT, Pretell EJ, Teale J, Garcia HH. 2006. Treatment of neurocysticercosis: current status and future research needs. Neurology 67:1120-1127.
8. Alvarez JI, Colegial CH, Castano CA, Trujillo J, Teale JM, Restrepo BI. 2002. The human nervous tissue in proximity to granulomatous lesions induced by Taenia solium metacestodes displays an active response. J. Neuroimmunol. 127:139-144.
9. Alvarez JI, Rivera J, Teale JM. 2008. Differential release and phagocytosis of tegument glycoconjugates in neurocysticercosis: implications for immune evasion strategies. PLoS Negl. Trop. Dis. 2:e218. doi:10.1371/journal.pntd.0000218.
10. Cardona AE, Restrepo BI, Jaramillo JM, Teale JM. 1999. Development of an animal model for neurocysticercosis: immune response in the central nervous system is characterized by a predominance of gamma delta T cells. J. Immunol. 162:995-1002.
11. Obregon-Henao A, Gil DL, Gomez DI, Sanzon F, Teale JM, Restrepo BI. 2001. The role of N-linked carbohydrates in the antigenicity of Taenia solium metacestode glycoproteins of 12, 16 and 18 kD. Mol. Biochem. Parasitol. 114:209-215.
12. Restrepo BI, Llaguno P, Sandoval MA, Enciso JA, Teale JM. 1998. Analysis of immune lesions in neurocysticercosis patients: central nervous system response to helminth appears Th1-like instead of Th2. J. Neuroimmunol. 89:64-72.
13. Restrepo BI, Alvarez JI, Castano JA, Arias LF, Restrepo M, Trujillo J, Colegial CH, Teale JM. 2001. Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infect. Immun. 69: 4554-4560.
14. Cardona AE, Teale JM. 2002. Gamma/delta T cell-deficient mice exhibit reduced disease severity and decreased inflammatory response in the brain in murine neurocysticercosis. J. Immunol. 169:3163-3171.
15. Adalid-Peralta L, Fragoso G, Fleury A, Sciutto E. 2011. Mechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infections. Int. J. Biol. Sci. 7:1412-1426.
16. Geijtenbeek TB, Gringhuis SI. 2009. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 9:465-479. 17. Kerrigan AM, Brown GD. 2011. Syk-coupled C-type lectins in immunity. Trends Immunol. 32:151-156.
17. Kerrigan AM, Brown GD. 2011. Syk-coupled C-type lectins in immunity. Trends Immunol. 32:151-156.
18. Garcia-Vallejo JJ, van Kooyk Y. 2009. Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostasis. Immunol. Rev. 230:22-37.
19. Gundra UM, Mishra BB, Wong K, Teale JM. 2011. Increased disease severity of parasite-infected TLR2β/β mice is correlated with decreased central nervous system inflammation and reduced numbers of cells withalternatively activated macrophage phenotypes in a murine model of neurocysticercosis. Infect. Immun. 79:2586-2596.
20. Mishra BB, Gundra UM, Teale JM. 2011. STAT6β/β mice exhibit decreased cells with alternatively activated macrophage phenotypes and enhanced disease severity in murine neurocysticercosis. J. Neuroimmunol. 232:26-34.
21. Dan JM, Kelly RM, Lee CK, Levitz SM. 2008. Role of the mannose receptor in a murine model of Cryptococcus neoformans infection. Infect. Immun. 76:2362-2367.
22. Rajaram MV, Brooks MN, Morris JD, Torrelles JB, Azad AK, Schlesinger LS. 2010. Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses. J. Immunol. 185:929-942.
23. van de Veerdonk FL, Marijnissen RJ, Kullberg BJ, Koenen HJ, Cheng SC, Joosten I, van den Berg WB, Williams DL, van der Meer JW, Joosten LA, Netea MG. 2009. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 5:329-340.
24. Zenaro E, Donini M, Dusi S. 2009. Induction of Th1/Th17 immune response by Mycobacterium tuberculosis: role of dectin-1, mannose receptor, and DC-SIGN. J. Leukoc. Biol. 86:1393-1401.
25. Gazi U, Martinez-Pomares L. 2009. Influence of the mannose receptor in host immune responses. Immunobiology 214:554-561.
26. Haslam SM, Restrepo BI, Obregon-Henao A, Teale JM, Morris HR, Dell A. 2003. Structural characterization of the N-linked glycans from Taenia solium metacestodes. Mol. Biochem. Parasitol. 126:103-107.
27. Lee SJ, Evers S, Roeder D, Parlow AF, Risteli J, Risteli L, Lee YC, Feizi T, Langen H, Nussenzweig MC. 2002. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 295:1898-1901.
28. Alvarez JI, Teale JM. 2006. Breakdown of the blood brain barrier and blood-cerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC. J. Neuroimmunol. 173:45-55.
29. Mishra BB, Gundra UM, Wong K, Teale JM. 2009. MyD88-deficient mice exhibit decreased parasite-induced immune responses but reduced disease severity in a murine model of neurocysticercosis. Infect. Immun. 77:5369-5379.
30. Cardona AE, Sasse ME, Liu L, Cardona SM, Mizutani M, Savarin C, Hu T, Ransohoff RM. 2008. Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood 112:256-263.
31. Mizutani M, Pino PA, Saederup N, Charo IF, Ransohoff RM, Cardona AE. 2012. The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J. Immunol. 188: 29-36.
32. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2βdelta delta C(T) method. Methods 25:402-408.
33. Dinarello CA. 2011. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117:3720-3732.
34. Maroso M, Balosso S, Ravizza T, Iori V, Wright CI, French J, Vezzani A. 2011. Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 8:304-315.
35. Alvarez JI, Krishnamurthy J, Teale JM. 2009. Doxycycline treatment decreases morbidity and mortality of murine neurocysticercosis: evidence for reduction of apoptosis and matrix metalloproteinase activity. Am. J. Pathol. 175:685-695.
36. Cardona AE, Gonzalez PA, Teale JM. 2003. CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response. Infect. Immun. 71:2634-2642.
37. Alvarez JI, Teale JM. 2007. Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature. Brain Res. 1169:98-111.
38. Ma YP, Ma MM, Cheng SM, Ma HH, Yi XM, Xu GL, Liu XF. 2008. Intranasal bFGF-induced progenitor cell proliferation and neuroprotection after transient focal cerebral ischemia. Neurosci. Lett. 437:93-97.
39. Ren JM, Finklestein SP. 2005. Growth factor treatment of stroke. Curr. Drug Targets CNS Neurol. Disord. 4:121-125.
40. Youn JI, Collazo M, Shalova IN, Biswas SK, Gabrilovich DI. 2012. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 91:167-181.
41. Van Ginderachter JA, Beschin A, De Baetselier P, Raes G. 2010. Myeloid- derived suppressor cells in parasitic infections. Eur. J. Immunol. 40:2976-2985.
42. Alves CM, Silva DA, Azzolini AE, Marzocchi-Machado CM, Carvalho JV, Pajuaba AC, Lucisano-Valim YM, Chammas R, Liu FT, Roque- Barreira MC, Mineo JR. 2010. Galectin-3 plays a modulatory role in the life span and activation of murine neutrophils during early Toxoplasma gondii infection. Immunobiology 215:475-485.
43. Gabrilovich DI, Nagaraj S. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9:162-174.
44. Sinha P, Okoro C, Foell D, Freeze HH, Ostrand-Rosenberg S, Srikrishna G. 2008. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J. Immunol. 181:4666-4675.
45. Villota GE, Gomez DI, Volcy M, Franco AF, Cardona EA, Isaza R, Sanzon F, Teale JM, Restrepo BI. 2003. Similar diagnostic performance for neurocysticercosis of three glycoprotein preparations from Taenia solium metacestodes. Am. J. Trop. Med. Hyg. 68:276-280.
46. Agrawal SM, Lau L, Yong VW. 2008. MMPs in the central nervous system: where the good guys go bad. Semin. Cell Dev. Biol. 19:42-51.
47. Alvarez JI, Teale JM. 2008. Multiple expression of matrix metalloproteinases in murine neurocysticercosis: implications for leukocyte migration through multiple central nervous system barriers. Brain Res. 1214:145-158.
48. Justicia C, Panes J, Sole S, Cervera A, Deulofeu R, Chamorro A, Planas AM. 2003. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J. Cereb. Blood Flow Metab. 23:1430-1440.
49. Tsuda Y, Takahashi H, Kobayashi M, Hanafusa T, Herndon DN, Suzuki F. 2004. Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 21:215-226.
50. Bronte V, Zanovello P. 2005. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5:641-654.
51. Henderson NC, Sethi T. 2009. The regulation of inflammation by galectin- 3. Immunol. Rev. 230:160-171.
52. Ponomarev ED, Maresz K, Tan Y, Dittel BN. 2007. CNS-derived interleukin- 4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J. Neurosci. 27:10714-10721.
53. Yan YP, Lang BT, Vemuganti R, Dempsey RJ. 2009. Galectin-3 mediates post-ischemic tissue remodeling. Brain Res. 1288:116-124.
54. Flugel A, Odoardi F, Nosov M, Kawakami N. 2007. Autoaggressive effector T cells in the course of experimental autoimmune encephalomyelitis visualized in the light of two-photon microscopy. J. Neuroimmunol. 191:86-97.
55. Marttila-Ichihara F, Turja R, Miiluniemi M, Karikoski M, Maksimow M, Niemela J, Martinez-Pomares L, Salmi M, Jalkanen S. 2008. Macrophage mannose receptor on lymphatics controls cell trafficking. Blood 112:64-72.
56. Rodriguez PC, Hernandez CP, Morrow K, Sierra R, Zabaleta J, Wyczechowska DD, Ochoa AC. 2010. L-Arginine deprivation regulates cyclin D3 mRNA stability in human T cells by controlling HuR expression. J. Immunol. 185:5198-5204.
57. Solito S, Bronte V, Mandruzzato S. 2011. Antigen specificity of immune suppression by myeloid-derived suppressor cells. J. Leukoc. Biol. 90:31-36.
58. Ma G, Pan PY, Eisenstein S, Divino CM, Lowell CA, Takai T, Chen SH. 2011. Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 34:385-395.
59. Liu FT. 2005. Regulatory roles of galectins in the immune response. Int. Arch. Allergy Immunol. 136:385-400.
60. Saeland E, van Vliet SJ, Backstrom M, van den Berg VC, Geijtenbeek TB, Meijer GA, van Kooyk Y. 2007. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma. Cancer Immunol. Immunother. 56:1225-1236.
61. van Vliet SJ, van Liempt E, Saeland E, Aarnoudse CA, Appelmelk B, Irimura T, Geijtenbeek TB, Blixt O, Alvarez R, van Die I, van Kooyk Y. 2005. Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells. Int. Immunol. 17:661-669.
62. Medeiros A, Chiribao ML, Ubillos L, Festari MF, Saldana J, Robello C, Dominguez L, Calvete JJ, Osinaga E. 2008. Mucin-type O-glycosylation in Mesocestoides vogae (syn corti). Int. J. Parasitol. 38:265-276.
63. Ubillos L, Medeiros A, Cancela M, Casaravilla C, Saldana J, Dominguez L, Carmona C, Le Pendu J, Osinaga E. 2007. Characterization of the carcinoma-associated Tk antigen in helminth parasites. Exp. Parasitol. 116:129-136.
64. Restrepo BI, Obregon-Henao A, Mesa M, Gil DL, Ortiz BL, Mejia JS, Villota GE, Sanzon F, Teale JM. 2000. Characterisation of the carbohydrate components of Taenia solium metacestode glycoprotein antigens. Int. J. Parasitol. 30:689-696.
65. Mariani MM, Kielian T. 2009. Microglia in infectious diseases of the central nervous system. J. Neuroimmune Pharmacol. 4:448-461. 66. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958-969.
66. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958-969.
67. Colton CA, Wilcock DM. 2010. Assessing activation states in microglia. CNS Neurol. Disord. Drug Targets 9:174-191.
68. Ribechini E, Greifenberg V, Sandwick S, Lutz MB. 2010. Subsets, expansion and activation of myeloid-derived suppressor cells. Med. Microbiol. Immunol. 199:273-281.
69. Youn JI, Gabrilovich DI. 2010. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 40:2969-2975.
70. Jenkins SJ, Allen JE. 2010. Similarity and diversity in macrophage activation by nematodes, trematodes, and cestodes. J. Biomed. Biotechnol. 2010:262609. doi:10.1155/2010/262609.
71. Reyes JL, Terrazas LI. 2007. The divergent roles of alternatively activated macrophages in helminthic infections. Parasite Immunol. 29:609-619.
72. Reyes JL, Espinoza-Jimenez AF, Gonzalez MI, Verdin L, Terrazas LI. 2011. Taenia crassiceps infection abrogates experimental autoimmune encephalomyelitis. Cell. Immunol. 267:77-87.
73. Yin B, Ma G, Yen CY, Zhou Z, Wang GX, Divino CM, Casares S, Chen SH, Yang WC, Pan PY. 2010. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J. Immunol. 185:5828-5834.